You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,492,416


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,492,416
Title:2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
Abstract: The invention concerns 2-oxo-1-pyrrolidine derivatives of formula I, ##STR00001## wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.
Inventor(s): Kenda; Beno t (Emines, BE), Pasau; Patrick (Chastre, BE), Lallemand; Benedicte (Namur, BE)
Assignee: UCB Pharma, S.A. (Brussels, BE)
Application Number:13/222,477
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,492,416
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,492,416: A Detailed Analysis

Introduction

United States Patent 8,492,416, like any other patent, involves a complex interplay of claims, scope, and the broader patent landscape. To fully comprehend this patent, it is crucial to delve into its specific claims, the context in which it was granted, and how it fits into the larger intellectual property ecosystem.

Background on Patent 8,492,416

While the specific details of Patent 8,492,416 are not provided in the sources, we can infer general principles from similar patents and the processes involved in patent granting.

Claims and Scope

Claim Structure

Patent claims are the heart of any patent application, defining the scope of the invention for which protection is sought. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to and further limiting an independent claim[4].

Subject Matter Eligibility

The USPTO's 2024 guidance update on AI patent eligibility provides valuable insights into how claims are evaluated. For a claim to be patent-eligible, it must integrate a judicial exception (such as an abstract idea or natural phenomenon) into a practical application. This involves assessing whether the claim imposes meaningful limits on the exception, transforming it into patent-eligible subject matter[1].

Example Analysis

Consider a hypothetical claim similar to those analyzed in the 2024 USPTO guidance. If a claim involves merely receiving, separating, and processing audio signals using mathematical algorithms, it might be deemed ineligible as it is directed to an abstract idea without a practical application. However, if the claim specifies the use of these processed audio signals in a real-time speech recognition system to enhance voice command accuracy, it would likely be considered patent-eligible due to its practical application and tangible benefits[1].

Patent Landscape Analysis

Importance of Patent Landscape

A patent landscape analysis is crucial for understanding the strategic positioning of a patent within its technological field. This analysis goes beyond simple patentability searches to provide a comprehensive view of the entire technology area, helping businesses and R&D teams make informed decisions about their intellectual property strategies[5].

Identifying Key Players

In a patent landscape analysis, identifying key players and their patent portfolios is essential. This involves looking at the top patent owners in the relevant technology area and analyzing their focus and investment in that niche. For instance, a company with a significant portion of its patent portfolio dedicated to a specific niche technology may indicate a strong market presence and potential competition[5].

Saturation and Innovation

Patent landscape analysis also helps in identifying areas of high patent saturation, which can signal the need to pivot to newer, less crowded inventive spaces. This is particularly important for long-term strategic planning, as high saturation can indicate mature technologies with limited room for innovation[5].

Practical Applications and Technological Improvements

Real-World Impact

For a patent to be considered valid, it must demonstrate a practical application that results in tangible benefits. This could include improvements in related technical fields, such as enhanced accuracy in real-time speech recognition or better performance in voice-controlled systems. These practical applications are what distinguish patent-eligible claims from those that are merely abstract ideas[1].

Case Law and Guidance

Recent case law and USPTO guidance emphasize the importance of integrating judicial exceptions into practical applications. This ensures that the claimed invention offers a concrete technological improvement rather than just routine data processing steps without any inventive concept[1].

The Role of AI in Patent Development

AI-Assisted Inventions

The 2024 USPTO guidance clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies. This means that AI’s role as a tool does not exclude inventions from eligibility, provided there is significant human contribution[1].

Patent Prosecution Process

Filing and Examination

The process of obtaining a patent involves several steps, including filing a provisional patent application, followed by a non-provisional application within a year. The patent examiner reviews the application for patentability, which can take several years. If the application is not patentable as submitted, arguments and amended claims must be presented, and if necessary, an appeal can be made to an appeal board or the U.S. court system[4].

Costs and Commercial Considerations

The cost of patenting can be substantial, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and significantly more for international patents. Commercial partners often cover these costs, especially if there is a reasonable likelihood of recovering them later[4].

Key Takeaways

  • Subject Matter Eligibility: Claims must integrate judicial exceptions into practical applications to be patent-eligible.
  • Practical Applications: Patents must demonstrate tangible benefits and technological improvements.
  • Patent Landscape Analysis: Essential for strategic IP decisions and identifying areas of high patent saturation.
  • AI-Assisted Inventions: Evaluated on equal footing with other technologies, provided there is significant human contribution.
  • Patent Prosecution: Involves multiple steps, including filing, examination, and potential appeals.

FAQs

Q: What is the significance of integrating judicial exceptions into practical applications in patent claims? A: Integrating judicial exceptions into practical applications ensures that the claimed invention offers a concrete technological improvement, making it patent-eligible.

Q: How does the use of AI impact the patentability of an invention? A: The use of AI does not impact subject matter eligibility; the focus remains on the claimed invention itself, ensuring AI-assisted inventions are evaluated equally.

Q: What is the purpose of a patent landscape analysis? A: A patent landscape analysis provides a comprehensive view of the entire technology area, helping businesses make informed decisions about their IP strategies.

Q: What are the typical costs associated with obtaining a U.S. patent? A: The costs can range from $8,000 to $20,000 for a U.S. non-provisional patent application, and significantly more for international patents.

Q: How long does the patent prosecution process typically take? A: The process can take two to five years, involving filing, examination, and potential appeals.

Sources

  1. Understanding the 2024 USPTO Guidance Update on AI Patent - Mintz
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov
  3. Patent Claims Research Dataset - USPTO
  4. Intellectual Property Protection - KU Office of Research
  5. Patent Landscape Analysis - AcclaimIP

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,492,416

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,492,416

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom0004297.8Feb 23, 2000

International Family Members for US Patent 8,492,416

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 1265862 ⤷  Subscribe PA2016013 Lithuania ⤷  Subscribe
European Patent Office 1452524 ⤷  Subscribe 300815 Netherlands ⤷  Subscribe
European Patent Office 1452524 ⤷  Subscribe CA 2016 00013 Denmark ⤷  Subscribe
European Patent Office 1452524 ⤷  Subscribe 16C1001 France ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.